Adma Biologics, Inc. SEC filings ADMA
Adma Biologics, Inc. has 999 filings in SEC EDGAR's recent list, going back to Jul 10, 2006. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| CORRESP | Letter to the SEC | Jul 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2025 | — |
| NT 10-K | Filing | Mar 3, 2025 | Dec 31, 2024 |
| 15-12B | Deregistration | Jun 16, 2022 | — |
| 8-A12B | Filing | Dec 21, 2021 | — |
| 15-12B | Deregistration | Dec 21, 2021 | — |
| EFFECT | Filing | Aug 3, 2021 | — |
| CORRESP | Letter to the SEC | Jul 30, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2021 | — |
| 8-A12B | Filing | Dec 16, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 10, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 3, 2020 | — |
| EFFECT | Filing | Oct 15, 2019 | — |
| CORRESP | Letter to the SEC | Oct 10, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2019 | — |
| CT ORDER | Filing | Apr 16, 2019 | — |
| CT ORDER | Filing | Sep 24, 2018 | — |
| EFFECT | Filing | May 31, 2018 | — |
| CORRESP | Letter to the SEC | May 29, 2018 | — |
| CT ORDER | Filing | May 3, 2018 | — |
| EFFECT | Filing | Nov 8, 2017 | — |
| CORRESP | Letter to the SEC | Nov 6, 2017 | — |
| CORRESP | Letter to the SEC | Nov 6, 2017 | — |
| CORRESP | Letter to the SEC | Oct 23, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2017 | — |
| CT ORDER | Filing | Sep 12, 2017 | — |
| EFFECT | Filing | Jun 28, 2017 | — |
| CORRESP | Letter to the SEC | Jun 26, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2017 | — |
| CT ORDER | Filing | Apr 25, 2016 | — |
| CT ORDER | Filing | Jun 2, 2015 | — |
| CT ORDER | Filing | Mar 10, 2015 | — |
| EFFECT | Filing | Dec 23, 2014 | — |
| CERTNAS | Auto-generated paper document | Nov 6, 2014 | — |
| 8-A12B | Filing | Nov 5, 2014 | — |
| DEFR14A | Filing | May 16, 2014 | — |
| CT ORDER | Filing | Apr 8, 2014 | — |
| EFFECT | Filing | Oct 16, 2013 | — |
| CORRESP | Letter to the SEC | Oct 16, 2013 | — |
| CORRESP | Letter to the SEC | Oct 16, 2013 | — |
| CORRESP | Letter to the SEC | May 1, 2013 | — |
| CORRESP | Letter to the SEC | Apr 30, 2013 | — |
| CORRESP | Letter to the SEC | Apr 30, 2013 | — |
| CORRESP | Letter to the SEC | Apr 25, 2013 | — |
| CORRESP | Letter to the SEC | Apr 23, 2013 | — |
| CORRESP | Letter to the SEC | Apr 23, 2013 | — |
| CT ORDER | Filing | Mar 4, 2013 | — |
| CT ORDER | Filing | Feb 20, 2013 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2013 | — |
| D | Filing | Jan 7, 2013 | — |
| CT ORDER | Filing | Aug 14, 2012 | — |
| EFFECT | Filing | Aug 13, 2012 | — |
| CORRESP | Letter to the SEC | Aug 9, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2012 | — |
| CT ORDER | Filing | Jul 9, 2012 | — |
| CORRESP | Letter to the SEC | Jul 3, 2012 | — |
| CORRESP | Letter to the SEC | Jun 22, 2012 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2012 | — |
| CORRESP | Letter to the SEC | Jun 15, 2012 | — |
| CORRESP | Letter to the SEC | Jun 5, 2012 | — |
| CORRESP | Letter to the SEC | Jun 4, 2012 | — |
| CORRESP | Letter to the SEC | May 23, 2012 | — |
| UPLOAD | Letter from the SEC | May 23, 2012 | — |
| UPLOAD | Letter from the SEC | May 9, 2012 | — |
| CORRESP | Letter to the SEC | May 8, 2012 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2012 | — |
| CORRESP | Letter to the SEC | Apr 24, 2012 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2012 | — |
| CORRESP | Letter to the SEC | Mar 29, 2012 | — |
| CORRESP | Letter to the SEC | Mar 23, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2012 | — |
| D | Filing | Feb 28, 2012 | — |
| 10KSB | Filing | Sep 12, 2008 | Jun 30, 2008 |
| 10QSB | Filing | Apr 8, 2008 | Mar 31, 2008 |
| 10QSB | Filing | Feb 12, 2008 | Dec 31, 2007 |
| 10QSB | Filing | Oct 24, 2007 | Sep 30, 2007 |
| 10KSB | Filing | Aug 16, 2007 | Jun 30, 2007 |
| 10QSB | Filing | Apr 25, 2007 | Mar 31, 2007 |
| 10QSB | Filing | Jan 30, 2007 | Dec 31, 2006 |
| 10QSB | Filing | Oct 19, 2006 | Sep 30, 2006 |
| 10SB12G | Filing | Jul 10, 2006 | — |
Showing 86 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ADMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ramsey, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1368514
- Former names
- R&R ACQUISITION VI, INC (until Feb 21, 2012)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.